Drawing for ASL PHARMACY

USPTO serial 85560203

ASL PHARMACY

Reviewed by CopyMark Law Group

Reg. 4848733Status 710
Filing date
Status date
Registration date
Nov 10, 2015
Examiner
BAKER, JORDAN A
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with ASL PHARMACY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Christine M. Baker

CHRISTINE M BAKER MINTZ LEVIN COHN FERRIS GLOVSKY & POPEO PC666 3RD AVE24TH FLNEW YORK, NY 10017-4040

Goods and services

ClassDescriptionStatusFirst use
005Antibacterial pharmaceuticals; antimicrobial preparations for inhibiting microbiological decomposition in food, beverages, animal feed and pharmaceuticals; dermatological pharmaceutical products; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; homeopathic pharmaceuticals for use in the treatment of sinusitis; inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; inhalers filled with anti-infectives; pharmaceutical anti-allergic preparations and substances; pharmaceutical antitussive-cold preparations; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for the treatment of sinusitis; pharmaceutical preparations for treating allergic rhinitis and asthma; pharmaceutical preparations for treating skin disorders; pharmaceutical preparations for use in chemotherapy; pharmaceutical preparations for use in dermatology; pharmaceutical products for ophthalmological use; pharmaceutical products for the treatment of viral and infectious diseases and cancer; pharmaceutical products for treating respiratory diseases and asthma; pharmaceuticals, namely, anti-infectives; synthetic peptides for pharmaceutical purposes; vitamin and mineral preparations for use as ingredients in the food and pharmaceutical industry; all of the above excluding pharmaceutical and nutraceutical preparations for the treatment of diseases of the digestive system, and food supplementsSECTION 8 - CANCELLED—
035Retail pharmacy services; Retail store pharmacy services in the field of prescription drugs; mail order of pharmaceuticals; Specialty pharmaceutical distributorship services; Pharmaceutical cost management for the health care benefit plans of others; Retail and online retail store pharmacy services in the field of prescription drugs, healthcare and beauty products; retail store and mail order pharmacy services in the field of prescription drugs and patient, prescription and drug therapy information; retail store services, namely, pharmacy, retail drug store and general merchandise store services; mail order of pharmaceuticals, specialty pharmaceutical distributorship services; pharmaceutical cost management for health care benefit plans for others; administering pharmacy reimbursement programs and services; promoting public awareness of the value of using generic drugs; processing mail order prescription drug refill orders in retail and central fill pharmacies; processing online and telephone prescription orders in retail and central fill pharmaciesSECTION 8 - CANCELLED—
044Pharmaceutical consultation; consulting with patients regarding the administration of medicine and the use of medical devices; providing a physician resource for clinical questions about medications; providing a web site featuring information about, and through which, customers can obtain information about general health topics, pharmaceutical therapies and disease state management; providing medical information regarding patients, prescription drugs and drug therapy; providing health care information and consulting services in the field of disease management and medical condition management; providing medical information regarding patients, prescription drugs and drug therapy; developing and managing comprehensive programs involving drug therapy and physician support services in the nature of providing consultation in the dispensing of pharmaceuticals for persons with chronic health issues; therapeutic pharmaceutical services, namely, the development and management of comprehensive programs comprising drug therapy and physician support services in the nature of providing consultation in the dispensing of pharmaceuticals for persons with chronic health issues; drug utilization review dispensing services, namely, identifying possible drug to drug interactions prior to dispensing new prescribed medications and possible drug allergic reactions given a patient's drug allergy historySECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 20, 2022C8..CANCELLED SEC. 8 (6-YR)—
Nov 10, 2015R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 27, 2015TMBNTTAB RELEASE CASE TO TRADEMARKS—
Aug 27, 2015OP.TOPPOSITION TERMINATED NO. 999999—
Aug 27, 2015OP.DOPPOSITION DISMISSED NO. 999999—
May 25, 2013OP.IOPPOSITION INSTITUTED NO. 999999—
Dec 11, 2012ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Nov 20, 2012PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 31, 2012NPUBNOTICE OF PUBLICATION—
Oct 16, 2012PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Oct 15, 2012ALIEASSIGNED TO LIE—
Oct 1, 2012CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 12, 2012TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 12, 2012CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 12, 2012TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 14, 2012CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 14, 2012CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 13, 2012DOCKASSIGNED TO EXAMINER—
Mar 12, 2012NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 8, 2012NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance